Regulation of RNA metabolism and cell growth control by SR protein kinases
SR 蛋白激酶对 RNA 代谢和细胞生长控制的调节
基本信息
- 批准号:8321712
- 负责人:
- 金额:$ 10.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2012-02-09
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAffectAgarAlternative SplicingAnimal ModelAttentionBrainCell NucleusCell SurvivalCell modelCellsControl AnimalCouplingCytoplasmDevelopmentDiseaseEmbryoEmbryonic DevelopmentEnzymesEventFamilyFamily memberFibroblastsFundingG2 PhaseGene ExpressionGeneticGenetic TranscriptionGenome StabilityGoalsHeartIndividualInterphaseKnock-outKnockout MiceLinkMammalian CellMammalsMediatingMetabolismModelingMusNuclear ImportNuclear TranslocationNude MiceOncogenesPathway interactionsPhasePhenotypePhosphorylationPhosphotransferasesPlayPositioning AttributePost-Transcriptional RegulationProcessProtein DephosphorylationProtein KinaseProteinsPublishingRNARNA SplicingRegulationResearchResearch PersonnelRoleSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSoft Agar AssaySorting - Cell MovementStructureSystemTestingThymus GlandTissuesTransgenic MiceTranslationsTumor SuppressionTumor Suppressor GenesTumor Suppressor ProteinsWorkbasecell growthdesignin vivoinsightinterestmRNA Exportmessenger ribonucleoproteinmetaplastic cell transformationmouse developmentmouse modelprogramsprotein complexresearch studyresponsesubcutaneoustumoryeast two hybrid system
项目摘要
Post-transcriptional regulation of gene expression is critical for cell growth control and animal
development. This project attacks SRPK1 and 2, two evolutionary conserved kinases that correspond to
the major kinase activity for the SR family of splicing factors and regulators in mammalian cells. SR proteins
are involved in many aspects of RNA metabolism, all of which appear to be regulated by phosphorylation.
Strikingly, we recently found that mouse embyo fibroblasts genetically deleted of SRPK1 are transformed in
the soft agar assay and in nude mice. Furthermore, SRPKs are localized in the cytoplasm and can be
induced to translocate to the nucelus in response to specific signals. Thus, SRPKs are fundamentally
important for cell growth control and the kinase system may be regulated by signaling.
Building upon our expertise established in the previous funding periods of this project, long-term
interest in post-transcriptional regulation of gene expression, and extensive published and unpublished
findings, we propose to continue this project under three specific aims for the next phase of research. Aim 1
is to develop conditional knockout mice models to determine the functional requirement for both SRPK1 and
2 during mouse development and characterize the kinase knockout mouse embryo fibroblasts to provide
genetic evidence that SRPKs regulate the function SR proteins in RNA metabolism in mammalian cells. Aim
2 is to address the putative tumor suppressor activity of SRPK1 by testing three specific hypotheses: (1)
SRPK1 may regulate alternative splicing of oncogenes and tumor supressors via SR proteins; (2) SRPK1-
mediated phosphorylation may act to reorganize newly exported mRNA-protein complex to regulate
translation in the cytoplasm; and (3) SRPK1-mediated phosphorylation may play a critical role in maintaining
genomic stability by modulating the coupling between transcription and splicing. Aim 3 is to understand how
SRPKs might be regulated by signaling. A panel of SRPK-interacting proteins have been identified and
many are known components of various signal transduction pathways. We design specific experiments to
understand how some specific signals may be transduced via SRPKs to regulate gene expression at post-
transcriptional levels. Together, the project will dissect an unprecedented cellular transformation pathway.
基因表达的转录后调控对于细胞生长调控和动物实验都是至关重要的
发展该项目攻击SRPK 1和2,这两种进化保守的激酶对应于
哺乳动物细胞中剪接因子和调节因子SR家族的主要激酶活性。SR蛋白
参与RNA代谢的许多方面,所有这些似乎都受到磷酸化的调节。
引人注目的是,我们最近发现,SRPK 1基因缺失的小鼠胚胎成纤维细胞转化为
软琼脂试验和裸鼠试验。此外,SRPKs定位于细胞质中,并且可以在细胞内表达。
在特定信号的作用下被诱导转移到珠心。因此,SRPK基本上
对于细胞生长控制很重要,并且激酶系统可以通过信号传导来调节。
基于我们在本项目前几个供资期建立的专业知识,
对基因表达转录后调控感兴趣,并广泛发表和未发表
根据研究结果,我们建议在下一阶段的研究中,根据三个具体目标继续这项计划。要求1
是开发条件性基因敲除小鼠模型,以确定SRPK 1和
2.小鼠发育过程中的特征性激酶敲除小鼠胚胎成纤维细胞,提供
SRPKs在哺乳动物细胞RNA代谢中调节SR蛋白功能的遗传学证据。目的
2是通过测试三个具体假设来解决SRPK 1的假定肿瘤抑制活性:(1)
SRPK 1可能通过SR蛋白调节癌基因和抑癌基因的选择性剪接;
介导的磷酸化可能起作用,重组新输出的mRNA-蛋白质复合物,以调节
SRPK 1介导的磷酸化可能在维持细胞质中的翻译中起关键作用。
通过调节转录和剪接之间的偶联来调节基因组稳定性。目标3是了解如何
SRPKs可能受信号传导调控。已经鉴定了一组SRPK相互作用蛋白,
许多是各种信号转导途径的已知组分。我们设计特定的实验,
了解一些特定的信号如何通过SRPKs转导来调节基因表达,
转录水平。总之,该项目将剖析一个前所未有的细胞转化途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIANG-DONG FU其他文献
XIANG-DONG FU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIANG-DONG FU', 18)}}的其他基金
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8734415 - 财政年份:2013
- 资助金额:
$ 10.5万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9081584 - 财政年份:2013
- 资助金额:
$ 10.5万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8915157 - 财政年份:2013
- 资助金额:
$ 10.5万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8647698 - 财政年份:2013
- 资助金额:
$ 10.5万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9310249 - 财政年份:2013
- 资助金额:
$ 10.5万 - 项目类别:
FUNCTION AND REGULATION OF THE HUMAN SPLICING FACTOR SC35
人类剪接因子 SC35 的功能和调控
- 批准号:
7845881 - 财政年份:2009
- 资助金额:
$ 10.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10.5万 - 项目类别:
Research Grant














{{item.name}}会员




